BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9393377)

  • 1. Comparing dichotomous screening tests when individuals negative on both tests are not verified.
    Chock C; Irwig L; Berry G; Glasziou P
    J Clin Epidemiol; 1997 Nov; 50(11):1211-7. PubMed ID: 9393377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of disease prevalence, true positive rate, and false positive rate of two screening tests when disease verification is applied on only screen-positives: a hierarchical model using multi-center data.
    Stock EM; Stamey JD; Sankaranarayanan R; Young DM; Muwonge R; Arbyn M
    Cancer Epidemiol; 2012 Apr; 36(2):153-60. PubMed ID: 21856264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of diagnostic tests without gold standards.
    Hui SL; Zhou XH
    Stat Methods Med Res; 1998 Dec; 7(4):354-70. PubMed ID: 9871952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytic methods for comparing two dichotomous screening or diagnostic tests applied to two populations of differing disease prevalence when individuals negative on both tests are unverified.
    Berry G; Smith CL; Macaskill P; Irwig L
    Stat Med; 2002 Mar; 21(6):853-62. PubMed ID: 11870821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.
    Håkonsen SJ; Pedersen PU; Bath-Hextall F; Kirkpatrick P
    JBI Database System Rev Implement Rep; 2015 May; 13(4):141-87. PubMed ID: 26447079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing two medical tests when results of reference standard are unavailable for those negative via both tests.
    Kondratovich MV
    J Biopharm Stat; 2008; 18(1):145-66. PubMed ID: 18161546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Roaming through methodology. XXXII. False test results].
    van der Weijden T; van den Akker M
    Ned Tijdschr Geneeskd; 2001 May; 145(19):906-8. PubMed ID: 11387865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflections on accuracy.
    Gambino B
    J Gambl Stud; 2006 Dec; 22(4):393-404. PubMed ID: 17096201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy.
    Adhikari EH; Macias D; Gaffney D; White S; Rogers VL; McIntire DD; Roberts SW
    Am J Obstet Gynecol; 2018 Oct; 219(4):408.e1-408.e9. PubMed ID: 29913173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the conditional false-positive rate for semi-latent data.
    van der Merwe L; Maritz JS
    Epidemiology; 2002 Jul; 13(4):424-30. PubMed ID: 12094097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized crossover trial of PAPNET for primary cervical screening.
    Irwig L; Macaskill P; Farnsworth A; Wright RG; McCool J; Barratt A; Simpson JM
    J Clin Epidemiol; 2004 Jan; 57(1):75-81. PubMed ID: 15019013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect.
    Walter SD; Macaskill P; Lord SJ; Irwig L
    Stat Med; 2012 May; 31(11-12):1129-38. PubMed ID: 22351623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
    Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
    Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and coverage of estimates of relative accuracy.
    Cheng H; Macaluso M; Hardin JM
    Ann Epidemiol; 2000 May; 10(4):251-60. PubMed ID: 10854959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Test Evaluation: Methods and Challenges.
    Gambino B
    J Gambl Stud; 2018 Dec; 34(4):1109-1138. PubMed ID: 29368061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity, specificity, positive and negative predictive values: diagnosing purple mange.
    Collier J; Huebscher R
    J Am Acad Nurse Pract; 2010 Apr; 22(4):205-9. PubMed ID: 20409258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing diagnostic tests on benefit-risk.
    Pennello G; Pantoja-Galicia N; Evans S
    J Biopharm Stat; 2016; 26(6):1083-1097. PubMed ID: 27548805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjusting for differential-verification bias in diagnostic-accuracy studies: a Bayesian approach.
    de Groot JA; Dendukuri N; Janssen KJ; Reitsma JB; Bossuyt PM; Moons KG
    Epidemiology; 2011 Mar; 22(2):234-41. PubMed ID: 21228702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard.
    Joseph L; Gyorkos TW; Coupal L
    Am J Epidemiol; 1995 Feb; 141(3):263-72. PubMed ID: 7840100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting.
    Chacón L; Mateos ML; Holguín Á
    J Clin Virol; 2017 Jul; 92():11-13. PubMed ID: 28501753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.